Metraipolis › archive › dc_57ef90359abd
Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP+ Homeostasis — Europe PMC PMID:41608616
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41608616
- DOI
- 10.7150/ijbs.121033
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:49:34.086Z
- SHA-256 of the archived text
4365f3ac92e0083803029d58982c00cd13e8a4bc25cca46ab6c56e2a111091e3- Stable URL of this page
https://metraipolis.com/documento/dc_57ef90359abd
How to cite
Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP+ Homeostasis — Europe PMC PMID:41608616 — Europe PMC (en), https://europepmc.org/article/MED/41608616 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57ef90359abd (Metraipolis archive dc_57ef90359abd, sha256 4365f3ac92e0083803029d58982c00cd13e8a4bc25cca46ab6c56e2a111091e3)
BibTeX
@misc{dc57ef90359abd,
title = {Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP+ Homeostasis — Europe PMC PMID:41608616},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41608616},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57ef90359abd; sha256 4365f3ac92e0083803029d58982c00cd13e8a4bc25cca46ab6c56e2a111091e3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608616. Agents can read the archived copy with the MCP tool read_document.